Results 61 to 70 of about 609,595 (394)

Bridging Barriers to Cervical Cancer Screening in Transgender Men: A Scoping Review

American Journal of Men's Health, 2020
Estimates of high-risk human papillomavirus (HPV) infection and susceptibility to HPV-related cancer in transgender men (TM) are comparable to prevalence rates found in cisgender women.
Navdeep Dhillon, J. Oliffe, M. Kelly, J. Krist   +3 more
semanticscholar   +1 more source

Screening for Cervical Cancer

Bioscientia Medicina : Journal of Biomedicine and Translational Research, 2021
Screening is a public health intervention administered to a target population without symptoms. Screening is not performed to diagnose a disease, but to identify individuals with a higher likelihood of developing the disease itself or a precursor to the disease. Not all diseases are suitable for screening programs. The following criteria help determine
Legiran, Irfannuddin, Siti Nurmaini, Patiyus Agustiansyah, Rizal Sanif   +4 more
openaire   +3 more sources

Determinants of a GP visit and cervical cancer screening examination in Great Britain. [PDF]

PLoS ONE, 2017
OBJECTIVE:In the UK, women are requested to attend a cervical cancer test every 3 years as part of the NHS Cervical Screening Programme. This analysis compares the determinants of a cervical cancer screening examination with the determinants of a GP ...
Alexander Michael Labeit, Frank Peinemann   +1 more
doaj   +1 more source

A Study on Cervical Cancer Screening Amongst Nurses in Lagos University Teaching Hospital, Lagos, Nigeria [PDF]

, 2011
Cancer of the cervix is the commonest genital tract malignancy in the female, and it has been ranked second to breast cancer. It has positive association with infection of human papillomavirus.
A. A. A. Adeyomoye, D. C. Dolapo, D. F. Awodele, I. O. Awodele, O. Awodele, V. Kwashi   +5 more
core   +2 more sources

Comparison of characteristics of cervical cancer screening history between cervical adenocarcinoma and cervical squamous cell carcinoma [PDF]

Xin yixue
Objective To comparatively analyze the characteristics of cervical cancer screening history between patients with cervical adenocarcinoma and cervical squamous cell carcinoma， and to preliminarily evaluate the efficacy of cervical cancer screening for ...
Ye Minjuan, Li Jing, Chen Zifei, He Junxian, Chen Lifa, Zhang Yu
doaj   +1 more source

The Future of Cervical Cancer Screening. [PDF]

Int J Womens Health
Cervical cancer remains a significant health concern, particularly in developing countries, where it is a leading cause of cancer-related deaths among women. Innovative technologies have emerged to improve the efficiency, cost-effectiveness, and sensitivity of cervical cancer screening and treatment methods.
Goldstein A, Gersh M, Skovronsky G, Moss C.   +3 more
europepmc   +4 more sources

Performance of p16INK4a ELISA as a primary cervical cancer screening test among a large cohort of HIV-infected women in western Kenya: a 2-year cross-sectional study. [PDF]

, 2016
ObjectiveA biomarker with increased specificity for cervical dysplasia compared with human papillomavirus (HPV) testing would be an attractive option for cervical cancer screening among HIV-infected women in resource-limited settings. p16(INK4a) has been
Huchko, Megan J, Maloba, May, Reuschenbach, Miriam, Smith-McCune, Karen, von Knebel Doeberitz, Magnus, Wu, Tara J   +5 more
core   +1 more source

Challenges and opportunities associated with cervical cancer screening programs in a low income, high HIV prevalence context

BMC Women's Health, 2020
Background Cervical cancer is a leading cause of death among Cameroon women. The burden of cervical cancer is in part traceable to the inadequate understanding of socio-contextual determinants of access to screening and prevention opportunities.
A. Adedimeji, Rogers Ajeh, Amanda J. Pierz, Relindis Nkeng, Jackson Jr. Ndenkeh, Norbert Fuhngwa, D. Nsame, Miriam Nji, A. Dzudie, K. Anastos, Philip E. Castle   +10 more
semanticscholar   +1 more source

ShcD adaptor protein drives invasion of triple negative breast cancer cells by aberrant activation of EGFR signaling

Molecular Oncology, EarlyView.
We identified adaptor protein ShcD as upregulated in triple‐negative breast cancer and found its expression to be correlated with reduced patient survival and increased invasion in cell models. Using a proteomic screen, we identified novel ShcD binding partners involved in EGFR signaling pathways.
Hayley R. Lau, Hayley S. Smith, Begüm Alural, Claire E. Martin, Laura A. New, Manali Tilak, Sara L. Banerjee, Hannah N. Robeson, Nicolas Bisson, Anne‐Claude Gingras, Jasmin Lalonde, Nina Jones   +11 more
wiley   +1 more source

HPV self-sampling implementation strategies to engage under screened communities in cervical cancer screening: a scoping review to inform screening programs

Frontiers in Public Health
IntroductionHuman papillomavirus (HPV) testing as a method of cervical cancer screening can be performed by healthcare providers or by patients through self-sampling directly in the community, removing several barriers experienced by under screened ...
Madison M. Fullerton, Madison M. Fullerton, Caitlin Ford, Chelsea D’Silva, Bonnie Chiang, Se-Inyenede Onobrakpor, Holly Dievert, Huiming Yang, Jason Cabaj, Jason Cabaj, Noah Ivers, Noah Ivers, Sandra Davidson, Jia Hu, Jia Hu, Jia Hu   +15 more
doaj   +1 more source